cyc 202 has been researched along with meridianin g in 1 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (meridianin g) | Trials (meridianin g) | Recent Studies (post-2010) (meridianin g) |
---|---|---|---|---|---|
979 | 7 | 393 | 14 | 0 | 9 |
Protein | Taxonomy | cyc 202 (IC50) | meridianin g (IC50) |
---|---|---|---|
Dual specificity protein kinase CLK1 | Homo sapiens (human) | 0.53 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 5 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.588 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 5 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | 0.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Kier Joffe, EB; Franco, LH; Gompel, M; Leost, M; Meijer, L; Palermo, J; Puricelli, L | 1 |
1 other study(ies) available for cyc 202 and meridianin g
Article | Year |
---|---|
Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum.
Topics: Aminopyridines; Animals; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indole Alkaloids; Mice; Protein Kinase Inhibitors; Urochordata | 2004 |